What’s In This Video Webinar
Taking a drug product from clinical to commercial-scale production is a complex process with numerous variables to consider. Finding an appropriately sized CDMO to help you go to market can be difficult, especially when manufacturing capacity shortages are common and many CMOs focus on more established or high-volume products. Companies who are developing sterile products, such as injectable or ophthalmic dosage forms, must also ensure manufacturing sites are prepared for the challenges of aseptic manufacturing.
To find the right partner, you must know what to look for in a CDMO. In this webinar from Lubrizol Life Science Health (LLS Health), we will describe how LLS Health’s CDMO Division is meeting the need for commercial aseptic manufacturing capacity and explore key considerations when selecting a CDMO for commercial supply, including:
- The importance of flexibility and transparency
- Selecting the “right-sized” CDMO
- Strategies for reducing risk
- Best practices for project management
- Streamlining projects with a full-service CDMO